Takeda to invest ¥100B for plasma-derived drugs facility in Japan

Takeda Pharmaceutical (TAK) said on Thursday that it will invest about ¥100B to build a new manufacturing facility for plasma-derived therapies (PDTs) in Osaka, Japan.The Japanese...

Related Keywords

Belgium ,Osaka ,Japan ,Japanese ,Thomas Wozniewski ,Michael Vi , ,Takeda Pharmaceutical ,Stock Editorial ,Milano Furuta ,Japan Pharma Business Unit ,